RT Journal Article
SR Electronic
T1 QJHong Model for Novel Coronavirus Disease 2019 (COVID-19) in the United States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.30.23293233
DO 10.1101/2023.07.30.23293233
A1 Mehta, Aanand
A1 Hong, Qi-Jun
YR 2023
UL http://medrxiv.org/content/early/2023/07/31/2023.07.30.23293233.abstract
AB We present the methodology of the QJHong model, a machine learning predictive model we built to forecast the COVID-19 daily cases, number of daily deaths, fatality rate, reproductive number, and overall trends in the United States (both national and individual states). We measure the accuracy and compare it to other predictive models. Several forecast analyses consistently demonstrate that the QJHong model outperforms other models submitted to the COVID-19 Forecast Hub with regards to forecasting national data. The Forecast Hub is utilized by the Centers for Disease Control and Prevention (CDC) as a means of disseminating official public communications pertaining to the ongoing pandemic. As such, our model has been identified as a premier performer within this context.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the start-up funding provided by the School of Engineering for Matter, Transport, and Energy, Arizona State University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors